Targeting NF-κB signaling pathways represents a promising strategy in the treatment of NHL.14 In the present study, we demonstrated that DHI, a small natural compound, induces proliferation inhibition and apoptosis of NHL cells in vitro and in vivo. Here, NFKB1 is linked to non-Hodgkin lymphoma.